Loading...

Vinergy Capital Inc.

VIN.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.20
$-0.01(-4.76%)
Canadian Market opens in NaNh NaNm

Vinergy Capital Inc. (VIN.CN) Stock Competitors & Peer Comparison

See (VIN.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
VIN.CNCA$0.20-4.76%20.2M-0.67-CA$0.30N/A
CURA.TOCA$5.24+25.66%4.1B-11.91-CA$0.44N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.79-0.51%2.9B13.43CA$0.58N/A
GTII.CNCA$10.81+11.44%2.5B16.38CA$0.66N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$11.15+16.88%1.9B-14.19-CA$0.80N/A
CRON.TOCA$3.84+2.40%1.5B-128.00-CA$0.03N/A
TLRY.TOCA$10.82+14.62%1.3B-0.54-CA$20.09N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

VIN.CN vs CURA.TO Comparison April 2026

VIN.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VIN.CN stands at 20.2M. In comparison, CURA.TO has a market cap of 4.1B. Regarding current trading prices, VIN.CN is priced at CA$0.20, while CURA.TO trades at CA$5.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VIN.CN currently has a P/E ratio of -0.67, whereas CURA.TO's P/E ratio is -11.91. In terms of profitability, VIN.CN's ROE is -0.79%, compared to CURA.TO's ROE of -0.30%. Regarding short-term risk, Volatility data is not available for a full comparison. VIN.CN has daily volatility of N/A and CURA.TO has daily volatility of 28.34.Check CURA.TO's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions